AlphaGrep UK
VRTX icon

AlphaGrep UK’s Vertex Pharmaceuticals VRTX Stock Holding History

AlphaGrep UK’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$320K Buy
+613
New +$314K 0.1% 459
2026
Q2 		– Sell
-774
Closed -$346K – 975
2026
Q1 		$346K Buy
774
+14
+2% +$6.53K 0.1% 441
2025
Q4 		$345K Buy
+760
New +$328K 0.12% 356

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

AlphaGrep UK's VRTX Position: Q3 2026 in Review

AlphaGrep UK opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 613 shares worth $320K. The stake represents 0.1% of the portfolio and ranks #459 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in VRTX as recently as Q1 2026.

AlphaGrep UK first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $346K in Q1 2026. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • AlphaGrep UK held 613 shares of Vertex Pharmaceuticals worth $320K as of Q3 2026.
  • Vertex Pharmaceuticals was a new AlphaGrep UK position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.1% of AlphaGrep UK's portfolio in Q3 2026, its #459 holding.
  • AlphaGrep UK first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Vertex Pharmaceuticals position peaked at $346K in Q1 2026.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.